Literature DB >> 21432135

BSE safety standards: An evaluation of public health policies of Japan, Europe, and USA.

Gino C Matibag1, Manabu Igarashi, Hiko Tamashiro.   

Abstract

Since the advent of bovine spongiform encephalopathy (BSE) in the United Kingdom in 1986, new BSE cases have recently become rare. However, in Japan and the United States, positive cases have started to be seen recently. The rise in BSE cases paved the way for the human form of this disease, the variant Creutzfeldt-Jakob disease (vCJD). The observed trends in the UK may be attributed to effective implementation of public health policies coupled with increased vigilance through advancement in science and technology, or they may well be a reflection of the natural disease progression. We aim to discuss the BSE chronology of events, and compare examination methods, costs and cost-efficiency, management, and public policies of Japan, Europe, and the USA.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; bovine spongiform encephalopathy; mad cow disease; public health policy; transmissible spongiform encephalopathy

Year:  2005        PMID: 21432135      PMCID: PMC2723415          DOI: 10.1007/BF02897706

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  23 in total

1.  Predicted vCJD mortality in Great Britain.

Authors:  A C Ghani; N M Ferguson; C A Donnelly; R M Anderson
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

2.  Projection of creutzfeldt-jakob disease frequency based on cadaveric dura transplantation in Japan.

Authors:  Chikuma Hamada; Tetsuji Sadaike; Masanori Fukushima
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

3.  Japan plans blood-donor restrictions to combat vCJD.

Authors:  Ichiko Fuyuno
Journal:  Nature       Date:  2005-03-17       Impact factor: 49.962

4.  Bovine spongiform encephalopathy. Taking stock of the issues.

Authors:  R H Kimberlin
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

Review 5.  Can Creutzfeldt-Jakob disease be transmitted by transfusion?

Authors:  P Brown
Journal:  Curr Opin Hematol       Date:  1995-11       Impact factor: 3.284

6.  Predicting the size of the vCJD epidemic in France.

Authors:  Annick Alpérovitch; Robert G Will
Journal:  C R Biol       Date:  2002-01       Impact factor: 1.583

7.  Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update.

Authors:  G A Wells; S A Hawkins; R B Green; A R Austin; I Dexter; Y I Spencer; M J Chaplin; M J Stack; M Dawson
Journal:  Vet Rec       Date:  1998-01-31       Impact factor: 2.695

8.  Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

Authors:  P Brown; L Cervenáková; L M McShane; P Barber; R Rubenstein; W N Drohan
Journal:  Transfusion       Date:  1999 Nov-Dec       Impact factor: 3.157

Review 9.  Bovine spongiform encephalopathy and human health.

Authors:  D M Taylor
Journal:  Vet Rec       Date:  1989-10-14       Impact factor: 2.695

10.  vCJD risk in the Republic of Ireland.

Authors:  Michael S Harney; Azra C Ghani; C A Donnelly; Rory McConn Walsh; Michael Walsh; Rachel Howley; Francesca Brett; Michael Farrell
Journal:  BMC Infect Dis       Date:  2003-11-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.